...

首页> 外文期刊>Liver transplantation and surgery: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win? (editorial; comment)

【24h】

Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win? (editorial; comment)

机译：原发性胆汁性肝硬化患者的移植前熊去氧胆酸治疗和肝移植：双赢，双赢？（社论;评论）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Liver transplantation and surgery: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society》 |1999年第4期|共4页
作者
Benner KG;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学各论;
关键词
Cholagogues and Choleretics; Liver Cirrhosis; Biliary; Liver Transplantation; 利胆药和促胆汁分泌药; 肝硬化; 胆汁性; 肝移植; 术前用药法; 熊去氧胆酸;

机译：Cholagogues and Choleretics;Liver Cirrhosis;Biliary;Liver Transplantation;利胆药和促胆汁分泌药;肝硬化;胆汁性;肝移植;术前用药法;熊去氧胆酸;

相似文献

外文文献
中文文献
专利

1. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win? (editorial; comment) [J] . Benner KG Liver transplantation and surgery: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society . 1999,第4期

机译：原发性胆汁性肝硬化患者的移植前熊去氧胆酸治疗和肝移植：双赢，双赢？（社论;评论）
2. Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. [J] . Rabahi N, Chretien Y, Gaouar F, Gastroenterologie clinique et biologique . 2010,第4a5期

机译：重度原发性胆汁性肝硬化患者仅对熊去氧胆酸没有反应时，使用熊去氧胆酸，布地奈德和霉酚酸酯的三联疗法。
3. Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? Response [J] . Sato Ken, Hosonuma Kenichi, Kusano Motoyasu, The American Journal of Gastroenterology . 2015,第7期

机译：熊去氧胆酸和苯扎贝特联合治疗原发性胆汁性肝硬化：自身免疫性肝病中类固醇时代的终结？响应
4. Ursodeoxycholic Acid therapy Affects the Cytokine Network and Plays An Immunomodulatory Role in Patients With Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis [C] . M. G. Neuman, P. Angulo, I. M. Malkiewicz, Falk Symposium . 2003

机译：核糖核酸酸治疗影响细胞因子网络，并对初级硬化胆管炎和原发性胆汁肝硬化患者发挥免疫调节作用
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Recurrent Primary Biliary Cirrhosis: Peritransplant Factors and Ursodeoxycholic Acid Treatment Post-Liver Transplant [O] . Jennifer E. Guy, Peiqing Qian, Jeffrey A. Lowell, -1

机译：复发性原发性胆汁性肝硬化：移植后的因素和熊去氧胆酸治疗肝移植后。
7. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation [O] . W R Kim, J J Poterucha, R A Jorgensen, 1997

机译：抗度学抗体是否会影响原发性胆汁肝硬化患者治疗的反应？核糖糖核酸治疗和肝移植的结果

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号